What Pelthos Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 8 | 21 |
| Total trades | 10 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 3,595 | 5,253 |
| Disposed | 2,169 | 5,956 |
| Net activity | +1,426 | −703 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Greenleaf Peter | Director | Jul 02 | Open-market sale · S | −85 | $27.27 | −$2.32K | 23,884 |
| Greenleaf Peter | Director | Jul 02 | Open-market sale · S | −712 | $26.00 | −$18.5K | 23,969 |
| Pauls Matthew | Director | Jul 02 | Open-market sale · S | −94 | $27.36 | −$2.57K | 14,364 |
| Pauls Matthew | Director | Jul 02 | Open-market sale · S | −692 | $26.00 | −$18K | 14,458 |
| Friedberg Ezra M | Director | Jul 02 | Open-market sale · S | −24 | $27.33 | −$656 | 81,042 |
| Friedberg Ezra M | Director | Jul 02 | Open-market sale · S | −534 | $26.03 | −$13.9K | 81,066 |
| Friedberg Ezra M | Director | Jun 15 | Open-market sale · S | −59 | $27.94 | −$1.65K | 81,600 |
| Friedberg Ezra M | Director | Jun 15 | Open-market sale · S | −224 | $27.12 | −$6.08K | 81,659 |
| Davis Todd C | Director | Jun 11 | Open-market buy · P | +503 | $28.73 | +$14.4K | 75,834 |
| Davis Todd C | Director | Jun 11 | Open-market buy · P | +35,445 | $27.80 | +$986K | 75,331 |
| Francis Knuettel Ii | CFO, Treas & Secty | May 22 | Open-market sale · S | −1,500 | $26.84 | −$40.3K | 11,316 |
| Francis Knuettel Ii | CFO, Treas & Secty | May 22 | Disposition to Issuer · D | −13,947 | — | — | 19,525 |
| Friedberg Ezra M | Director | May 14 | Withheld — tax / exercise cost · F | −144 | $27.01 | −$3.89K | 81,883 |
| Pauls Matthew | Director | Apr 02 | Open-market sale · S | −371 | $21.36 | −$7.93K | 15,150 |
| Pauls Matthew | Director | Apr 02 | Open-market sale · S | −415 | $20.52 | −$8.51K | 15,521 |
| Greenleaf Peter | Director | Apr 02 | Open-market sale · S | −377 | $21.36 | −$8.05K | 24,681 |
| Greenleaf Peter | Director | Apr 02 | Open-market sale · S | −420 | $20.52 | −$8.62K | 25,058 |
| Friedberg Ezra M | Director | Apr 02 | Open-market sale · S | −265 | $21.36 | −$5.66K | 82,027 |
| Friedberg Ezra M | Director | Apr 02 | Open-market sale · S | −293 | $20.51 | −$6.01K | 82,292 |
| Malamut Richard | Director | Apr 02 | Open-market sale · S | −280 | $21.36 | −$5.98K | 27,422 |
Loading...